WPP bid for Grey trumps the competition

Share this article:

Grey shareholders were being offered $1,005 per share under the deal. The agreement, which will allow Grey to operate under its own name, calls for 50 percent of Grey shares to be exchanged for cash and 50 percent of Grey shares to be exchanged for American Depository Shares of WPP.

Grey chairman and chief executive Ed Meyer reportedly will continue with the agency for two more years, according to a report in The New York Times.

In addition to its roster of blue-chip consumers clients, including Procter & Gamble, 3M, Mars and Warner Bros., Grey also operates the full-service medical agency Grey Healthcare Group.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...